Radcliffe Medical Education is delighted to introduce the live programme ‘SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure’ onsite in Barcelona, and online, around the world.

Chaired by Prof Scott Solomon (Boston, US), this session will bring together a leading international faculty of Prof John McMurray (Glasgow, UK), Prof Carolyn Lam (Singapore, SG) and Dr Muthiah Vaduganathan (Boston, US) to assess the latest data for SGLT2 inhibitors in heart failure (HF) and how to apply it in real-world practice.

This session will take place on Monday 29 August 2022, 12:45 - 13:45 CEST. Join us onsite in Barcelona, by registering to attend the ESC Congress 2022 today! 

Can’t join us at ESC Congress 2022 in Barcelona? This session will also be available to watch live virtually through the ESC 2022 congress platform. Register on the ESC website and select the online option. 

Register to Attend the ESC

Key Learning Objectives:

Following attendance at this symposium, physicians will be able to:

• Recall the results of key trials in HFmrEF and HFpEF in different patient sub-groups
• Describe how SGLT-2 inhibitors can be used across the range of LVEF
• Apply emerging diagnostic approaches for HFpEF and HFmrEF
• Implement best-practice strategies across the range of LVEF

This satellite symposium is supported by an unrestricted educational grant from AstraZeneca who had no involvement in the creation of the content.